Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seroprevalence of SARS-CoV-2-specific antibodies in the town of Ariano Irpino (Avellino, Campania, Italy): a population-based study.
Cerino P, Coppola A, Volzone P, Pizzolante A, Pierri B, Atripaldi L, Zollo M, Capasso M, Ascierto PA, Triassi M, Brambilla G, Perrella A, Bruzzese D, Buonerba C. Cerino P, et al. Among authors: buonerba c. Future Sci OA. 2021 Jan 12;7(4):FSO673. doi: 10.2144/fsoa-2020-0203. Future Sci OA. 2021. PMID: 33815819 Free PMC article.
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers.
Ferro M, Bruzzese D, Perdonà S, Mazzarella C, Marino A, Sorrentino A, Di Carlo A, Autorino R, Di Lorenzo G, Buonerba C, Altieri V, Mariano A, Macchia V, Terracciano D. Ferro M, et al. Among authors: buonerba c. Clin Chim Acta. 2012 Aug 16;413(15-16):1274-8. doi: 10.1016/j.cca.2012.04.017. Epub 2012 Apr 20. Clin Chim Acta. 2012. PMID: 22542564
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml.
Ferro M, Bruzzese D, Perdonà S, Marino A, Mazzarella C, Perruolo G, D'Esposito V, Cosimato V, Buonerba C, Di Lorenzo G, Musi G, De Cobelli O, Chun FK, Terracciano D. Ferro M, et al. Among authors: buonerba c. PLoS One. 2013 Jul 4;8(7):e67687. doi: 10.1371/journal.pone.0067687. Print 2013. PLoS One. 2013. PMID: 23861782 Free PMC article.
The use of interferon in melanoma patients: a systematic review.
Di Trolio R, Simeone E, Di Lorenzo G, Buonerba C, Ascierto PA. Di Trolio R, et al. Among authors: buonerba c. Cytokine Growth Factor Rev. 2015 Apr;26(2):203-12. doi: 10.1016/j.cytogfr.2014.11.008. Epub 2014 Nov 22. Cytokine Growth Factor Rev. 2015. PMID: 25511547 Review.
A Review of Hemp as Food and Nutritional Supplement.
Cerino P, Buonerba C, Cannazza G, D'Auria J, Ottoni E, Fulgione A, Di Stasio A, Pierri B, Gallo A. Cerino P, et al. Among authors: buonerba c. Cannabis Cannabinoid Res. 2021 Feb 12;6(1):19-27. doi: 10.1089/can.2020.0001. eCollection 2021. Cannabis Cannabinoid Res. 2021. PMID: 33614949 Free PMC article. Review.
Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19.
Andolfo I, Russo R, Lasorsa VA, Cantalupo S, Rosato BE, Bonfiglio F, Frisso G, Abete P, Cassese GM, Servillo G, Esposito G, Gentile I, Piscopo C, Villani R, Fiorentino G, Cerino P, Buonerba C, Pierri B, Zollo M, Iolascon A, Capasso M. Andolfo I, et al. Among authors: buonerba c. iScience. 2021 Apr 23;24(4):102322. doi: 10.1016/j.isci.2021.102322. Epub 2021 Mar 17. iScience. 2021. PMID: 33748697 Free PMC article.
Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2.
Cerino P, Gallo A, Pierri B, Buonerba C, Di Concilio D, Cuomo MC, Vassallo L, Lo Conte G, Coppola A, Pizzolante A, Boccia G, Ferrucci V, Atripaldi L, Triassi M, Pacella D, Cennamo M, Romano P, Sorbo TM, Furno A, Catapano O, Contina A, Perruolo G, D'Amora M, Terracciano D, Portella G. Cerino P, et al. Among authors: buonerba c. Front Public Health. 2021 Apr 29;9:649781. doi: 10.3389/fpubh.2021.649781. eCollection 2021. Front Public Health. 2021. PMID: 33996728 Free PMC article.
Regulatory Noncoding and Predicted Pathogenic Coding Variants of CCR5 Predispose to Severe COVID-19.
Cantalupo S, Lasorsa VA, Russo R, Andolfo I, D'Alterio G, Rosato BE, Frisso G, Abete P, Cassese GM, Servillo G, Gentile I, Piscopo C, Della Monica M, Fiorentino G, Russo G, Cerino P, Buonerba C, Pierri B, Zollo M, Iolascon A, Capasso M. Cantalupo S, et al. Among authors: buonerba c. Int J Mol Sci. 2021 May 20;22(10):5372. doi: 10.3390/ijms22105372. Int J Mol Sci. 2021. PMID: 34065289 Free PMC article.
The TNFRSF13C H159Y Variant Is Associated with Severe COVID-19: A Retrospective Study of 500 Patients from Southern Italy.
Russo R, Andolfo I, Lasorsa VA, Cantalupo S, Marra R, Frisso G, Abete P, Cassese GM, Servillo G, Esposito G, Gentile I, Piscopo C, Della Monica M, Fiorentino G, Russo G, Cerino P, Buonerba C, Pierri B, Zollo M, Iolascon A, Capasso M. Russo R, et al. Among authors: buonerba c. Genes (Basel). 2021 Jun 8;12(6):881. doi: 10.3390/genes12060881. Genes (Basel). 2021. PMID: 34201032 Free PMC article.
185 results